An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following ...

AI-assisted imaging improved prostate cancer diagnosis and biopsy decision-making in new research presented at EAU 2026.

A scan that makes prostate cancer cells “glow” could halve the number of men needing invasive biopsies, research suggests.

"This technology gives us a powerful tool to detect prostate cancer earlier and more precisely,” said Dr. James Howard.

Scans that make prostate cancer cells glow can eliminate the need for invasive biopsies and cut false positive—and they're ...

FDA approves Pylarify TruVu, a new prostate cancer PET imaging agent designed to expand access and improve detection of recurrent or metastatic disease.

Prostate cancers are either low-grade, low-risk forms that may be monitored but otherwise untreated, or they’re serious enough to require surgery and radiation. Monitoring can cause patients anxiety.

Nurse-led bladder volume support improved radiotherapy reproducibility and reduced repeat imaging in prostate cancer. Read ...

But does it cost too much?

The FDA has approved a new formulation of an F 18 prostate-specific membrane antigen imaging agent for men with prostate ...